<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">
LSX-Blog.png

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Advanced therapies: Gaining market access in a cha...

Listen to the final session in Phacilitate and LSX's (formerly known as Bio...

Read More

Overcoming commercialisation challenges in advance...

Learn more about the commercialisation of advanced therapies in the on-dema...

Read More

Why whistleblowing should be a boardroom issue in ...

On-demand webinar now available New EU-wide whistleblowing regulations have...

Read More

Learn about funding for advanced therapies 

In April-June 2018, LSX (formerly Biotech and Money) and Phacilitate ran a ...

Read More

On-demand Webinar Series: Funding, Commercialisati...

Learn more about the key funding, commercialisation, and market access chal...

Read More

[Webinar Recording] The Current State of the M&A L...

Are you considering M&A transactions as a potential exit strategy, step to ...

Read More

[Webinar] How to prepare a company for successful ...

On the 19th July at 13.00 (BST), we’re covering Cross Border M&A as an exit...

Read More

[Webinar Recording] The Anatomy of a successful IP...

On the 27th June, we spoke to an expert panel to discuss the how, when, wha...

Read More

Some highlights from Biotech and Money's recent Me...

On September 15th we spoke exclusively to a panel of MedTech CEOs and inves...

Read More

What are the strategies and key success factors fo...

Join us on Thursday 15th September, at 13:00pm BST for the next in our Biot...

Read More

The Brexit Effect: A Blow To UK Life Science Leade...

In this article,Claire Skentelberylooks at the potential consequences for t...

Read More

Who will be debating the pros and cons of the Brex...

Today marks exactly 3 weeks until Britain makes one of its biggest decision...

Read More

Add Your Response